Larissa Yemelyanova's Interview for the 15th International Eurasian Pharmaceutical Forum
On 29 February-1 March 2024, Almaty will host one of the greatest and most significant events of the pharmaceutical market – 15th International Eurasian Pharmaceutical Forum 2024, with AEQUITAS Law Firm acting as an official partner.
The firm's lawyers have many times participated in the Forum as delegates. This year they decided this would be a good time and socially useful if they share their opinions on the most relevant legal issues of the industry as speakers. Larissa Yemelyanova, AEQUITAS Counsel, will speak on an important topic of "Systemic risks of the legal environment within the EAEU and national Kazakhstani legislation affecting the circulation and availability of medicines on the Kazakhstan market".
The relevance of this topic selected by Larissa gave rise to great interest from the Forum organizers, because the participants of previous events actively discussed the most requested and hottest topics covering a wide range of issues both at the level of legislative initiatives and in the field of practical application of the current rules. So, what are the challenges the EAEU member states encounter today, and what problems do the companies face with? What are the risks to start working on right now? Larissa shared her insight into these and many other issues in a special interview on the website of the Forum.